Frontlight ResearchEarly access
Taking people in United StatesNo phase
Genetics of Uveitis
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- Cleveland, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- Jan 2011
- Expected to end
- Jan 2030
- Type of study
- Observational
- Record updated
- 4 March 2026
Who can take part
- Age
- 6 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Any patient above with the diagnosis of uveitis
- Any patient with a diagnosis of infectious uveitis such as toxoplasmosis retinochoroiditis, herpes associated retinitis
Who cannot take part
- Patients who are unable to give consent
- Patients in whom an adequated blood sample can not be obtained
Where in United States
- Cleveland Clinic FoundationCleveland, United StatesContact: Kimberly M Baynes, COATaking people
About the trial
What the trial wants to find out
In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.
The group in the trial
- Uveitis
Uveitis or infectious uveitis patients
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 4 March 2026